期刊文献+

冠状动脉支架置入术后再狭窄的治疗研究进展 被引量:9

Current Treatment of In-stent Restenosis
下载PDF
导出
摘要 药物洗脱支架的出现虽然明显降低再狭窄率;但是支架内再狭窄依然是一个重要的临床问题。最近,针对支架内再狭窄出现了很多新的治疗方案。现综述最近的临床数据和治疗进展,用以帮助临床决定裸支架和药物洗脱支架相关的再狭窄的治疗策略。 Although drug-eluting stents have drastically reduced the incidence of in-stent restenosis,it remains a highly significant clinical problem. Recently many new therapeutic options regarding this phenomenon have occurred. In this paper,we systematically reviewed the clinical trial data and treatment advances for helping to decide which therapeutic options related to bare-eluting stents and drug-eluting stents should be chosen.
作者 何晨 袁晋青
出处 《心血管病学进展》 CAS 2016年第4期350-353,共4页 Advances in Cardiovascular Diseases
基金 国家自然科学基金面上项目(81470486)
关键词 药物洗脱支架 经皮冠状动脉介入治疗 支架再狭窄 Drug-eluting stents Percutaneous coronary intervention In-stent restenosis
  • 相关文献

参考文献32

  • 1Takeshi T,Kazushige K,Seiji H, et al. The incidence of peri-stent contrast stai-ning after paclitaxel-coated balloon dilatation for in-stent restenosis lesions : acomparison with drug-eluting stent[ J]. J Am Coll Cardiol ,2014,63( 12 Suppl):1A1884. 被引量:1
  • 2Cassese S,Byrne RA,Tada T,et al. Incidence and predictors of restenosis aftercoronary stenting in 10 004 patients with surveillance angiography[ J ]. Heart,2013,100 (2) :153-159. 被引量:1
  • 3Hara H,Aoki J,Tanabe K, et al. Incidence and predictors for late target lesionrevascularization after sirolimus-eluting stent implantation [ J ]. Circ J, 2013 ,77:988-994. 被引量:1
  • 4Hoppmann P, Koch W, Laugwitz KL,et al. Genetic risk of restenosis after per-cutaneous coronary interventions in the era of drug-eluting stents[ J] . Coron Ar-tery Dis,2014,25(8) :658-664. 被引量:1
  • 5Dangas GD, Claessen BE, Caixeta A,et al. In-Stent restenosis in the drug-elu-ting stent era[ J ]. J Am Coll Cardiol,2010,56(23 ) :1897-1907. 被引量:1
  • 6Minha S, Pichard AD, Waksman R, et al. In-stent restenosis of drug-elutingstents[ J]. Future Cardiol,2013 ,9(5) ;721-731. 被引量:1
  • 7Strauss BH. Diabetic patients receiving bare-metal stents : no option patients.[J]. J Am Coll Cardiol,2013,61(16) : 1686-1687. 被引量:1
  • 8Mavromatis K, Samady H, King SB. Revascularization in patients with diabe-tes: PCI or CABG or none at all[ J]. Curr Cardiol Rep,2015 ,17(3 ) :565. 被引量:1
  • 9Tocci G, Barbato E,Coluccia R,et al. Blood pressure levels at the time of per-cutaneous coronary revascularization and risk of coronary in-stent restenosis [ J ].Am J Hypertens,2016,29 (4) :509-518. 被引量:1
  • 10Taniwaki M, Stefanini GG, Silber S,et al. 4-Year clinical outcomes and predic-tors of repeat revascularization in patients treated with newgeneration drug,elu-ting stents: a report from the RESOLUTE All-Comers Trial ( A RandomizedComparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent forPercutaneous Coronary Intervention) [ J]. J Am Coll Cardiol,2014, 63( 16):1617-1625. 被引量:1

同被引文献68

引证文献9

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部